Pharma IT Denmark Technographics
Pharma IT Denmark Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Pharma IT Denmark and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 140 Pharma IT Denmark employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Pharma IT Denmark has purchased the following applications: Microsoft 365 for Collaboration in 2015, Joomla 3.9 for Web Content Management in 2015, Linkedin Ads for Digital Advertising Platform in 2020 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Pharma IT Denmark is running and its propensity to invest more and deepen its relationship with Microsoft , Joomla , Automattic or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Pharma IT Denmark revenues, which have grown to $20.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Pharma IT Denmark intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Pharma IT Denmark Tech Stack and Enterprise Applications
Pharma IT Denmark Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
|
Pharma IT Denmark Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Joomla | Legacy | Joomla 3.9 | Web Content Management | Content Management | n/a | 2015 | 2015 |
|
|
|
|
|
Web Content Management | Content Management |
|
2018 | 2018 |
|
Pharma IT Denmark CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Linkedin Ads | Digital Advertising Platform | CRM | n/a | 2020 | 2020 |
|
|
|
|
|
Marketing Analytics | CRM |
|
2015 | 2015 |
|
|
|
|
|
Marketing Analytics | CRM |
|
2021 | 2021 |
|
|
|
|
|
Tag Management | CRM |
|
2020 | 2020 |
|
Pharma IT Denmark TRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Governance, Risk and Compliance | TRM |
|
2023 | 2023 |
|
|
|
|
|
Governance, Risk and Compliance | TRM |
|
2024 | 2024 |
|
Pharma IT Denmark IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2019 | 2019 |
|
Pharma IT Denmark CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Security (AppSec) | CyberSecurity |
|
2021 | 2021 |
|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2018 | 2018 |
|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2022 | 2022 |
|
IT Decision Makers and Key Stakeholders at Pharma IT Denmark
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Pharma IT Denmark Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||